Homepage / Technology / For one health-care venture capitalist, the search for ‘another miracle’ turns personal
Les Gambling establishments en Ligne en France 2024 200% Reward + 300 Free Rotates LevelUp Internet casino Melbourne En İyi ve Güvenilir Casino Siteleri Canlı Casino Siteleri 2023 Listesi En İyi ve Güvenilir Casino Siteleri Canlı Casino Siteleri 2023 Listesi Le meilleur casino en ligne franзais Extra Casino avec le dйpфt minimal le in addition bas Yeni Casino Siteleri ᐈ Çevrimiçi Kumarhaneler Mart 2024 Les gambling establishments en ligne proposent une grande variйtй de jeux de internet casino gratuits. Türkiye’deki Resmi Web Sitesi Google Play, Türkiye’de kumar oyunlarına izin verecek Her Gün Tatil Olsa ORDU’DA PAZARTESİ GÜNÜ FINDIK FİYATI NASIL? كازينو اون لاين الكازينوهات الممتازة على الإنترنت ألعاب الكازينو المباشرة مينا كازينو العر Google Play, Türkiye’de kumar oyunlarına izin verecek Domain Sorgulama & Domain Fýrsatlarý Canlı Casino Siteleri: 2024 Güvenilir Siteler Seçilmiştir Golden Easter Slot İncelemesi 2024, Demoyu Ücretsiz Oynayın Golden Easter Slot İncelemesi 2024, Demoyu Ücretsiz Oynayın 1xbet Türkiye Giriş Empieza Kayıt 202 Kumar Ve Kumarhaneler Hakkında Pek İlginç 21 Bilgi Kumarhane Doğru Yazımı Nedir? Tdk Ile Kumarhane Kelimesinin Doğru Yazılışı! Mobilbahiste En İyi Kumar Bonusları Ve Kazançlar Mobilbahis Giriş Sayfası On Line Casino Siteleri En Iyi Casino Siteleri 2024 Mostbet: Türkiye’de Internet Casino Mostbet Online Slotlar Ve Canlı-casin Pin Up Casino Oyna Türkiye, Pinup’un Sah Web Sites Ifade Haberleri Son Dakika Ifade Hakkında Güncel Haber Ve Bilgiler “önceliğimiz Transferin Önünü Açmak, Görüştüğümüz Yerler Var” On Line Casino Nuh’un Gemisi Deluxe Resort & Spa, Kıbrıs Bonus Veren Siteler 3 000 Den Fazla Online Oyunu Ücretsiz Oyna En Tehlikeli Kumar Oyunu Ekşi Sözlük Deneme Bonusu Veren Siteler Deneme Bonusu 2024 Explore the Magic of WildCardCity Güvenilir Bahis Siteleri En İyi Kumar Siteleri Balıkesir Triatlonuna Avrupadan Ödül Tricks of the Aviator gambling establishment game by Spribe Çevrim Içi Kumar Siteleri “bonus” Yalanıyla Kandırıyor En Güvenilir Canlı On Line Casino Siteleri Xbetting-tips Com Uncovering the Abundant Tapestry of Ozwin Gambling establishment Evaluating Board Portal Providers Uncovering the Wealthy Tapestry of Ozwin On line casino Electronic Data Area Providers Evaluation Cobra Internet casino: Raising the Australian On the internet Video gaming Practical experience 4 Things to Search for in Safeguarded Cloud Safe-keeping Fastpay On line casino Australia – Simple and No-Taxation Wagering Web page officielle franзaise de Joka Gambling establishment The Software Development Universe Game Woo Internet casino – Enjoy Slot machine games around australia Ostdeutsche Biersorten What Are Virtual Data Rooms? Vitamin D Receptor Polymorphisms Revue du Casino BlackLabel Faktory, kterй ovlivnujн hodnocenн ceskэch online kasin How to Make the Most of Your Web Development Organization and Advertising Efforts L’essor des casinos en ligne en France Boost Meeting Efficiency With Boardroom Technology Developments WildJoker Casino WildCardCity On line casino – Guaranteed Australian Gambling Portal WildCardCity Casino – The Ideal On the internet Gambling establishment within australia Modern Technologies Produce Sharing Documents Online Faster and More Protect Free Virtual Info Room pertaining to Speedy Due Diligence A Review of Data Area Software For people who do buiness Five Board Bedroom Features Which will help You Acquire a More Productive Boardroom Electronic Systems To your Business Understanding Legal Terms and Laws in Today’s World The Laws and Contracts of Hollywood: A Sunset Blvd. Tale Legal Discussion Between Johnny Cash and Antonin Scalia Legal Insights: What Teens Should Know Legal Issues and Exceptions: What You Need to Know Legal Insights and Expert Analysis Celebrity Dialogue: Legal Matters in the 21st Century Famous Personalities Discuss Legal Issues The Boys in the Boat: Legal Advisors and The Quest for Legal Knowledge Understanding Legal Matters: Q&A on Criminal Law, Joint Ventures, and More Enticing Title The Departed: Understanding Basic Work Requirements and Legal Rights Youth Slang Blog Article Legal Insights: A Journey into the World of Law The Ins and Outs of Legal Matters: Everything You Need to Know Legal Insights and Trends: A Rap Guide Mysterious Legal Matters Unveiled Insights and Information: Understanding Various Laws and Regulations Famous People of the 21st Century The Circle of Legal Life The Intersection of Fashion Law, Legal Translation, and THC Oil: A Modern Legal Guide Legal Q&A: Understanding Joinder Federal Rules and More Understanding Legal Terms and Conditions: A Comprehensive Guide Understanding Legal Documentation in a Fun Way! Understanding Legal Aspects: From Islamic Law of Inheritance to Farm Law Protests Understanding Legal Rights: A Guide to Legal Regulations and Requirements Understanding Legal Guidelines and Agreements Famous 21st Century People in Conversation Mysterious Legal Matters Unveiled Legal Matters and Real Estate: A Conversation Between Cameron Boyce and Donald Trump Understanding Legal Expertise and Why It Matters Legal FAQs and Expert Services Understanding Legal Ramifications: Common Law Ontario Health Benefits and More The Ins and Outs of Legal Requirements: From FBI Academy Physical Requirements to Silver Lake Fishing Rules The Legal Underworld: Understanding the Significance of Laws and Rights Legal Conversations: A Dialogue Between Jon Jones and Chadwick Boseman Legal Beats: Bobcats, Real Estate, Babysitting, and More

Technology

For one health-care venture capitalist, the search for ‘another miracle’ turns personal

It’s been less than a year since Jonathan Silverstein, a venture capitalist at health-care fund OrbiMed, received the diagnosis that changed everything.

Parkinson’s disease at age 49. A potentially more aggressive, inherited form, driven by a mutation in a gene called GBA. It affects up to 10 percent of Americans with Parkinson’s, and — as for other forms of the neurodegenerative disease — there is no cure, or even treatments that slow its course.

In recent months, Silverstein and his wife, Natalie, set up the Silverstein Foundation, raised $6 million from donors and gave $10 million of their own money to fund half a dozen promising projects and start a new company.

“I’m a venture capitalist, and what a venture capitalist is, is a problem-solver,” Silverstein said from OrbiMed’s New York offices. “This was a problem that was not just impacting me, but another 100,000 people around the globe.”

His nonprofit foundation has three main goals: first, find a way to halt progression of Parkinson’s with GBA. Next, identify a regenerative approach to repair the damage it wreaks. And finally, find a way to prevent it altogether.

Accomplishing even just the first would be to do something that’s never been done. Despite years of effort and capital — from the Michael J. Fox Foundation for Parkinson’s Research to funding from Google founder Sergey Brin — treatments for Parkinson’s disease have remained as elusive as those for other devastating neurodegenerative conditions, like Alzheimer’s.

“It has been extremely challenging, and many clinical trials have failed,” said Dr. Dimitri Krainc, chairman of the department of neurology and director of the Center for Rare Neurological Diseases at Northwestern University Feinberg School of Medicine. “However, we have learned important lessons from these failures.”

The disease was first described two centuries ago, in 1817, by British surgeon James Parkinson. In a document he called “An Essay on the Shaking Palsy,” Parkinson described a condition characterized by “involuntary tremulous motion, with lessened muscular power.”

We know now that Parkinson’s results from loss of brain cells, including those that produce the chemical messenger dopamine, important for coordinating movement. Treatments have been developed to provide symptomatic relief, such as levodopa, which helps replenish the brain’s supply of dopamine, but those have a set of problems of their own. Over time, people gradually need to increase the dose, and the medicines can lead to involuntary movement called dyskinesia.

The bigger problem, though, is that levodopa and other approved agents aren’t neuroprotective, said Krainc, “meaning that they do not prevent neurons from degenerating.”

Recent advancements in genetics provide some hope for better drug targets — including, according to Krainc, for the kind of Parkinson’s that Silverstein has, driven by a mutation in GBA.

The GBA gene is responsible for creating a protein known as GCase, or glucocerebrosidase, important for helping clear junk out of cells. And work is underway already: A clinical trial from Sanofi’s Genzyme unit is ongoing, and, in January, drugmaker Allergan bought an exclusive option to acquire a company called Lysosomal Therapeutics, whose lead program also focuses on GBA-associated Parkinson’s. Krainc is a co-founder of Lysosomal Therapeutics and chairs its scientific advisory board.

“There is a real need for disease-modifying treatment,” Allergan CEO Brent Saunders told CNBC.

Silverstein said he hopes the most advanced drugs will be able to help him, but he doesn’t plan on depending on them. After his diagnosis, he sent out a massive call for any work in Parkinson’s with GBA.

“We were just floored with the response,” he said. Hundreds of ideas flowed in — “some of them a little bit crazier than others” — but about 80 he deemed worth looking at more closely.

Since then, the Silverstein Foundation has made six funding grants to academic labs and private biotech companies, and received a $5 million donation from drugmaker Celgene.

Being a patient as well as a venture capitalist has changed Silverstein’s approach.

“As a venture capitalist, your first boss is your investors, so returns are the first thing that you have to be focused on,” he said.

That can lead to less risk-taking than might lead to bigger advances.

“But when you’re a patient, you come at it from a completely different viewpoint,” Silverstein said. “You’re not interested in incremental change. You’re interested in cures.”

Wednesday, along with OrbiMed and gene therapy biotech RegenXBio, the foundation announced the launch of a new company called Prevail Therapeutics. The founders of rare-disease drug giant Alexion, Leonard Bell and Stephen Squinto, are joining the board.

Silverstein knows firsthand the odds, and the timelines of traditional drug development are stacked against him. It’s estimated only 1 in 10 experimental compounds that enter human trials make it to market, and it takes years to get through the FDA approval process.

But a piece of advice, he said, has remained with him: “Be hopeful.”

He’s also determined. Julian Adams, a drug developer who met Silverstein two decades ago, recalled learning of his diagnosis and offering sympathies.

“I got this very rapid turnaround,” Adams said of Silverstein’s response: “‘I don’t need your sympathies; I need your brains and I need a cure.'”

Adams joined the Silverstein Foundation’s scientific advisory board, he said, “10 seconds later.”

“He’s so deeply respected in his field,” Natalie Silverstein, Jonathan’s wife of 17 years, said from their home in Manhattan. “The rallying around him has been incredible.”

One of his biggest successes, Silverstein recently recounted, is a drug called Strensiq, sold by Alexion for a rare, genetic bone disease called hypophosphatasia. He described seeing a baby, whose mother had been told she wouldn’t live past a few more months, receive a dose of the medicine when she was just a few weeks old.

She’s now 9, said Silverstein, who’s friends with her mom on Facebook. She’s “riding bikes and climbing trees and all those sorts of things.”

“I’ve seen miracles happen,” Silverstein said. “And … now I’ve got to create another miracle.”

More from Modern Medicine:
The new sickle cell drug that was 25 years in the making
Scientists treat diabetes and obesity with genetically altered skin grafts
Revolutionary day care for Alzheimer’s sufferers: Dementia villages

Source: Tech CNBC
For one health-care venture capitalist, the search for ‘another miracle’ turns personal

Comments are closed.